Fig. 2

Study profile. RDT, rapid diagnostic test; AQAS, fixed-dose combination amodiaquine–artesunate; AL, artemether–lumefantrine; SAE, serious adverse event
Study profile. RDT, rapid diagnostic test; AQAS, fixed-dose combination amodiaquine–artesunate; AL, artemether–lumefantrine; SAE, serious adverse event